Doliente, Michelle .

HRN: 05-68-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2023
CEFUROXIME 750MG (VIAL)
07/13/2023
07/19/2023
IV
375mg
Q8hr
Complete Fracture, Close, Displaced Distal 3rd Radius Left; Oblique Fracture, Close Middle 3rd Ulna Left
Rejected 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines